Obagi Medical – Nu-Derm System – Normal to Dry – Skin Transformation Trial Kit (OMP, Inc.)
Welcome to the PulseAid listing for the Obagi Medical – Nu-Derm System – Normal to Dry – Skin Transformation Trial Kit drug offered from OMP, Inc.. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: | OMP, Inc. |
NON-PROPRIETARY NAME: | Octinoxate, Zinc Oxide |
SUBSTANCE NAME: | |
TYPE: | HUMAN OTC DRUG |
PHARMA CLASS: | |
ROUTE: | |
DOSAGE FORM: | KIT |
MARKETING CATEGORY NAME: | UNAPPROVED DRUG OTHER |
START MARKETING DATE: | 2015-11-16 |
END MARKETING DATE: | 0000-00-00 |
Obagi Medical – Nu-Derm System – Normal to Dry – Skin Transformation Trial Kit HUMAN OTC DRUG Details:
Item Description | Obagi Medical – Nu-Derm System – Normal to Dry – Skin Transformation Trial Kit from OMP, Inc. |
LABELER NAME: | OMP, Inc. |
DEA SCHEDULE: | |
ACTIVE STRENGTH: | () |
START MARKETING DATE: | 2015-11-16 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 62032-528_2b445250-ab56-4ed1-9ea3-186817d47090 |
PRODUCT NDC: | 62032-528 |
APPLICATION NUMBER: |